Literature DB >> 7859931

Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive?

M A Banerji1, R L Chaiken, D Gordon, J G Kral, H E Lebovitz.   

Abstract

Insulin resistance in black Americans with non-insulin-dependent diabetes mellitus (NIDDM) is found in only 60% of those with a body mass index (BMI) of < 30 kg/m2, suggesting that NIDDM can occur independent of peripheral insulin resistance. When insulin resistance is present, it is not necessarily correlated with obesity. Numerous studies have shown that increased amounts of intra-abdominal adipose tissue are associated with various metabolic abnormalities. We therefore investigated whether the occurrence of insulin resistance in black NIDDM men could be explained by the pattern of body adipose tissue distribution rather than total adiposity. Twenty-two near-normoglycemic black men (fasting plasma glucose [mean +/- SD] = 104 +/- 10 mg/dl, HbA1c = 4.6 +/- 0.78%, age 48.9 +/- 9.2 years, and BMI 26.5 +/- 2.4 kg/m2) were studied. The euglycemic insulin clamp with 1 mU.kg-1.min-1 insulin infusion and D-[3-3H]glucose was used to measure insulin action. Whole-body computed tomography with 22 scans was used to determine body composition. Total body adipose tissue was 19.6 +/- 7.51, and the percentage of body fat was 27 +/- 7. Glucose disposal ranged from 2.5 to 8.1 mg.kg-1.min-1 (10 men were insulin-sensitive and 12 were insulin-resistant). There was a strong inverse correlation between glucose disposal and the proportion of total adipose tissue in the intra-abdominal region (r = -0.78, P < 0.001), while there was no correlation between glucose disposal and total muscle volume, BMI, total adipose tissue volume, or total subcutaneous adipose tissue volume.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859931     DOI: 10.2337/diab.44.2.141

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Emerging paradigms for understanding fatness and diabetes risk.

Authors:  Steven R Smith; Eric Ravussin
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

2.  Neurolytic celiac plexus block enhances skeletal muscle insulin signaling and attenuates insulin resistance in GK rats.

Authors:  Jun Li; Tao Chen; Kun Li; Hongtao Yan; Xiaowei Li; Yun Yang; Yulan Zhang; Bingyin Su; Fuxiang Li
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

Review 3.  Insulin resistance.

Authors:  A J Krentz
Journal:  BMJ       Date:  1996-11-30

Review 4.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 5.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Role of resistant starch on diabetes risk factors in people with prediabetes: Design, conduct, and baseline results of the STARCH trial.

Authors:  Kara L Marlatt; Ursula A White; Robbie A Beyl; Courtney M Peterson; Corby K Martin; Maria L Marco; Michael J Keenan; Roy J Martin; Kayanush J Aryana; Eric Ravussin
Journal:  Contemp Clin Trials       Date:  2017-12-21       Impact factor: 2.226

7.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

8.  Is visceral fat responsible for the metabolic abnormalities associated with obesity?: implications of omentectomy.

Authors:  Samuel Klein
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

9.  The case of visceral fat: argument for the defense.

Authors:  Samuel Klein
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

10.  Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.

Authors:  Yoshinori Miyazaki; Ralph A DeFronzo
Journal:  Cardiovasc Diabetol       Date:  2009-08-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.